Former studies have demonstrated that TRPM2 can decrease ROS production 39 and ROS is positively correlated with ER stress 49; therefore, TRPM2 could promote ccRCC progression by reducing ER stress by decreasing ROS. Here, TRPM2 is linked to nonpapillary renal cell carcinoma.